HealthHIV HIV Prevention Certified Provider Certification Program 2025-2026
The HealthHIV HIV Prevention Certified Provider™ Certification Program is an online, self-paced CME accredited certification program composed of eight, 60-minute modules detailing the pertinent clinical and practice information that clinicians need to effectively implement HIV prevention interventions.
As the only national program providing a certification of the HIV prevention workforce, participants who complete the program will have an understanding of the foundation of HIV epidemiology and policy in the United States, the provider’s role in identifying HIV risk and new cases, high impact strategies to prevent HIV through status-neutral-navigation, clinical guidelines to implement PrEP, and a framework of cultural humility that improves clients’ access to and retention in care.
Upon successful completion of this program, participants earn a certification recognizing their designation as an HIV Prevention Certified Provider (HIVPCP™) and receive a listing in the national online directory alongside thousands of other HIV Prevention Certified Providers. The curriculum is updated annually and more frequently as needed, based on approval of new biomedical interventions and the release of evidence-based practices.
Target Audience
This activity is intended for providers (physicians, PAs, NPs, nurses, pharmacists), allied health professionals (navigators, case managers, social workers, disease intervention specialists, health educators) and other healthcare professionals involved in the care of patients at risk for acquiring HIV.
- Media: Enduring Material
- Release date: April 2, 2025
- Expiration date: April 2, 2027
- Time to Complete: 60 minutes per module
Educational Objectives
After completing this activity, the participant will be better able to:
- Determine patient risk of HIV infection and eligibility for HIV prevention strategies, such as PrEP, by initiating a patient-provider dialogue regarding sexual health and behavior to overcome HIV stigma
- Recognize population-based considerations for HIV prevention and/or PrEP (eg people experiencing homelessness, persons of child-bearing age, youth, and older adults)
- Facilitate access to HIV prevention strategies by effectively engaging with and connecting patients to resources throughout the PrEP care continuum (e.g., HIV testing, PrEP initiation and adherence, medical home)
- Differentiate current and emerging HIV PrEP options based on the latest guidelines regarding clinical use as well as recent evidence to support initiation, monitoring, and retention of diverse patients in HIV prevention services
Program Agenda
|
Module 1: HIV Prevention: Epidemiology, Interventions, and Strategies |
|
Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative |
|
Module 3: Biomedical Strategies for Preventing HIV |
|
Module 4: Enhancing Cultural Humility and Understanding Barriers to Care |
|
Module 5: PrEP Adherence & Persistence |
|
Module 6: Population-Based Considerations for PrEP |
|
Module 7: State of HIV Prevention and PrEP in 2025: Certification Maintenance for HIVPCPs |
|
Pharmacy-Based HIV Prevention and PrEP (HIVPCPRX) |
Accreditation, Credit, and Support
All modules are certified and participants can earn up to 8.0 credits/contact hours (CME, MOC, ANCC, ACPE, AAPA, ASWB) for completion of the certification program (7 modules). Pharmacists who complete all 7 modules of the certification program and the Pharmacy-Based HIV Prevention and PrEP module are eligible to receive the HIVPCPRX certification.
In support of improving patient care, this activity has been planned and implemented by HealthHIV. HealthHIV. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
HealthHIV designates this enduring material for a maximum of up to 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOC Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Participation information will be shared through the ACCME's Program and Activity Reporting System (PARS).
Physician Associate Credit Designation Statement
HealthHIV has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for up to 8.0 AAPA Category 1 CME credits. Approval is valid until April 2, 2027. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development
Successful completion of this nursing continuing professional development activity will be awarded up to 8.0 contact hours.
Please see below for the assigned pharmacology contact hours per module.
|
Module |
Hrs. |
|
Module 1: HIV Prevention: Epidemiology, Interventions, and Public Health Strategies |
none |
|
Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative |
none |
|
Module 3: Biomedical Strategies for Preventing HIV |
1.0 |
|
Module 4: Enhancing Cultural Humility and Understanding Barriers to Care |
none |
|
Module 5: PrEP Adherence & Persistence |
0.66 |
|
Module 6: Population-Based Considerations for PrEP |
none |
|
Module 7: State of HIV Prevention and PrEP in 2025: Certification Maintenance for HIVPCPs |
none |
|
Module 8: Pharmacy-Based HIV Prevention and PrEP (HIVPCPRX) |
0.75 |
Continuing Pharmacy Education
HealthHIV designates this continuing education activity for up to 8.0 contact hours (0.8 CEU) of the Accreditation Council for Pharmacy Education.
Type of Activity: Knowledge
Please see below for UAN numbers assigned to each module.
Module 1: HIV Prevention: Epidemiology, Interventions, and Public Health Strategies
UANJA4008396-0000-25-001-H02-P
Module 2: HIV Testing, Assessing Risk, and Maintaining Serostatus Negative
UANJA4008396-0000-25-002-H02-P
Module 3: Biomedical Strategies for Preventing HIV
UANJA4008396-0000-25-003-H02-P
Module 4: Enhancing Cultural Humility and Understanding Barriers to Care
UANJA4008396-0000-25-004-H02-P
Module 5: PrEP Adherence & Persistence
UANJA4008396-0000-25-005-H02-P
Module 6: Population-Based Considerations for PrEP
UANJA4008396-0000-25-006-H02-P
Module 7: State of HIV Prevention and PrEP in 2025: Certification Maintenance for HIVPCPs
UANJA4008396-0000-25-007-H02-P
Pharmacy-Based HIV Prevention and PrEP (HIVPCPRX)
UANJA4008396-0000-25-008-H02-P
|
|
Social Worker Continuing Education
As a Jointly Accredited Organization, HealthHIV is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses are approved under this program. Regulatory boards have the final authority on courses accepted for continuing education credit. Social workers completing this course receive up to 8.0 general continuing education credits.
Interprofessional Continuing Education (IPCE) Statement
This activity was planned by and for the healthcare team, and learners will receive up to 8.0 Interprofessional Continuing Education (IPCE) credits for learning and change.
Support Statement
This program has been supported by an independent educational grant from Gilead Sciences, Inc and ViiV Healthcare.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from HealthHIV the accredited provider do not have any relevant financial relationships to disclose with ineligible companies.
Faculty Disclosures
Please check each individual module for specific faculty disclosures.
Disclosure & Conflict of Interest Policy
HealthHIV is committed to providing high quality continuing education to healthcare professionals, as individuals and teams, with a protected space to learn, teach, and engage in scientific discourse free from influence from ineligible companies that may have an incentive to insert commercial bias into education. To that end, HealthHIV requires faculty, presenters, planners, staff, and other individuals who are in a position to control the content of this CE activity to disclose all financial relationships they have had in the past 24 months with ineligible companies as defined by the ACCME, as related to the content of this CE activity, regardless of the amount or their view of the relevance to the education. All identified COI will be thoroughly vetted and mitigated according to HealthHIV policy. These disclosures will be provided to learners prior to the start of the CE activity.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this CE activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the CE activity are those of the presenters and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit. Your certificate will be available on eHealthHIV.org. If you have questions regarding your certificate, please contact Beth Brooks via email at beth@healthhiv.org.
For information on applicability and acceptance of continuing education credit for this CE activity, please consult your professional licensing board.
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your Board Unique ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit (75% is required for ABS).
For Pharmacists, HealthHIV will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/.
About This Activity
HealthHIV is responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of this activity is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of HealthHIV.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of HealthHIV or any of its partners, providers, and/or supporters.